Biological features of premalignant disease in the human breast.

p53, the Cellular Gatekeeper for Growth and Division

1997 • 7,621 citations

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

Risk Factors for Breast Cancer in Women with Proliferative Breast Disease

1985 • 1,817 citations

Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

1993 • 1,018 citations

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1985 • 963 citations

Nuclear receptor coactivators and corepressors.

1996 • 917 citations

Neu-Protein Overexpression in Breast Cancer

1988 • 860 citations

Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS)

1986 • 829 citations

An Atlas of Subgross Pathology of the Human Breast With Special Reference to Possible Precancerous Lesions<xref ref-type="fn" rid="fn2">2</xref>

1975 • 761 citations

Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.

1988 • 703 citations

Intraductal carcinoma of the breast: Follow-up after biopsy only

1982 • 604 citations

Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas

1996 • 583 citations

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

1993 • 526 citations

A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer

1992 • 491 citations

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1992 • 415 citations

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

1987 • 411 citations

OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION

1987 • 409 citations

On the Origin and Progression of Ductal Carcinoma in the Human Breast2

1973 • 345 citations

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

1981 • 341 citations

Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci

1998 • 338 citations

The effect of age and menstrual cycle upon proliferative activity of the normal human breast

1988 • 314 citations

COMPARATIVE STUDIES OF CANCEROUS VERSUS NONCANCEROUS BREASTS

1945 • 288 citations

Genetic basis for p53 overexpression in human breast cancer.

1991 • 287 citations

A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle

1986 • 285 citations

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1990 • 283 citations

Implications of the p53 tumor-suppressor gene in clinical oncology.

1995 • 258 citations

Estrogen Receptor Expression in Benign Breast Epithelium and Breast Cancer Risk

1998 • 253 citations

Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue.

1987 • 230 citations

A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.

2000 • 228 citations

Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

1988 • 212 citations

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

1995 • 207 citations

Abnormal expression of wild type p53 protein in normal cells of a cancer family patient

1992 • 199 citations

COMPARATIVE STUDIES OF CANCEROUS VERSUS NONCANCEROUS BREASTS

1945 • 198 citations

Estrogen and progesterone receptors in the normal female breast.

1991 • 196 citations

Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine

1977 • 191 citations

c-erbB-2 expression in benign and malignant breast disease

1988 • 190 citations

A prospective study of benign breast disease and the risk of breast cancer

1992 • 178 citations

LOBULAR CARCINOMA IN ‐SITU.

1974 • 175 citations

The prevalence of carcinoma in situ in normal and cancer-associated breasts

1985 • 173 citations

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

1990 • 171 citations

Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences

2000 • 166 citations

Genetic divergence in the clonal evolution of breast cancer.

1996 • 164 citations

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

1990 • 163 citations

Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

1995 • 162 citations

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1993 • 157 citations

The p53 tumor suppressor gene in breast cancer

1994 • 151 citations

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Five-year observations concerning lobular carcinoma in situ

1996 • 149 citations

Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.

1998 • 148 citations

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.

1994 • 147 citations

Expression of p53 protein in infiltrating and in‐situ breast carcinomas

1991 • 145 citations

Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.

1995 • 141 citations

Cell kinetics of histologic variants ofin situ breast carcinoma

1986 • 140 citations

Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.

1989 • 138 citations

Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.

1994 • 135 citations

Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia

1999 • 134 citations

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1995 • 132 citations

Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1992 • 131 citations

The classification of ductal carcinoma in situ and its association with biological markers.

1994 • 128 citations

Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.

1995 • 128 citations

Identification of Myoepithelial Cells in Human and Rat-Breasts by Anti-Common Acute Lymphoblastic Leukemia Antigen Antibody A12

1986 • 127 citations

HER-2/neu Amplification in Benign Breast Disease and the Risk of Subsequent Breast Cancer

2000 • 127 citations

Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysis

1990 • 127 citations

Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.

1990 • 122 citations

Molecular genetic studies of early breast cancer evolution

1994 • 120 citations

Loss of heterozygosity in ductal carcinoma in situ of the breast

1995 • 113 citations

Immunohistochemical Detection of c-erbB-2 and p53 in Benign Breast Disease and Breast Cancer Risk

1998 • 108 citations

Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

1996 • 105 citations

The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues

1989 • 105 citations

Benign breast disease and breast cancer: A case‐control study in a cohort in italy

1991 • 103 citations

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.

1992 • 102 citations

Loss of heterozygosity in lobular carcinoma in situ of the breast

1995 • 94 citations

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry

1990 • 88 citations

Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells.

1986 • 86 citations

Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.

1997 • 86 citations

p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade

1993 • 86 citations

p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast

1997 • 86 citations

C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia

1991 • 85 citations

Allelic loss and the progression of breast cancer.

1995 • 82 citations

Anatomic indicators (histologic and cytologic) of increased breast cancer risk

1993 • 82 citations

p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.

1994 • 78 citations

Immunophenotype of intraductal carcinoma.

1996 • 77 citations

The neu-oncogene: More than a prognostic indicator?

1994 • 76 citations

Influence of age and gland topography on cell kinetics of normal human breast tissue.

1987 • 75 citations

The neu-protein and breast cancer

1995 • 74 citations

Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.

1993 • 73 citations

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein

1993 • 72 citations

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas

1997 • 71 citations

Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study

1989 • 70 citations

High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.

1996 • 70 citations

Estrogen receptor values in patients with benign breast disease

1979 • 67 citations

Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.

1995 • 67 citations

Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situ

1991 • 66 citations

Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast

1990 • 65 citations

Loss of heterozygosity on chromosome 11 q 13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction

1997 • 65 citations

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

1997 • 65 citations

bcl ‐2 expression in the spectrum of preinvasive breast lesions

1996 • 64 citations

Extensive apoptosis in ductal carcinoma in situ of the breast

1996 • 61 citations

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease

1994 • 52 citations

Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis

1995 • 52 citations

Epithelial stem cells and their possible role in the development of the normal and diseased human breast.

1993 • 52 citations

Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors

1997 • 48 citations

p53 accumulation in benign breast biopsy specimens

1995 • 44 citations

Immunohistochemical profile of invasive lobular carcinoma of the breast: Predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive

1993 • 43 citations

Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer

1997 • 43 citations

Relationship to benign breast disease to carcinoma of the breast.

1962 • 43 citations

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

1997 • 42 citations

Cell proliferation in fibrocystic disease and postmenopausal breast ducts measured by thymidine labeling

1982 • 41 citations

Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.

1992 • 39 citations

Flow cytometric and histological analysis of ductal carcinoma in situ of the breast

1990 • 39 citations

Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

1996 • 37 citations

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast

1995 • 35 citations

Receptors for estrogen and progesterone in breast carcinoma in situ.

1992 • 35 citations

Distribution of estrogen receptor in ductal carcinoma in situ of the breast.

1993 • 35 citations

The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates.

1996 • 35 citations

Immunohistochemical study ofneu protein overexpression in clinging in situ duct carcinoma of the breast

1993 • 33 citations

The p185 erbB2 protein is localized on cell organelles involved in cell motility

1993 • 33 citations

Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.

1986 • 32 citations

Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal‐deoxynucleotidyl‐transferase‐mediated dUTP‐FITC nick end labelling (TUNEL)

1997 • 31 citations

TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breast

1996 • 29 citations

Biophenotypes of Breast Carcinoma in situ Defined by Image Analysis of Biological Parameters

1996 • 28 citations

Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study

1994 • 27 citations

Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast

1996 • 24 citations

Modulation of biomarkers in minimal breast carcinoma

1998 • 24 citations

Feulgen DNA content and mitotic activity in proliferative breast disease. A comparison with ductal carcinoma in situ

1987 • 23 citations

Correlation between ploidy status, Erb-B2 and p53 immunohistochemical expression in primary breast carcinoma.

1995 • 17 citations

[Pathological characterization of atypical ductal hyperplasia of the breast].

1995 • 8 citations

Cell cycle analysis of normal, atrophic, and hyperplastic breast epithelium using two-color multiparametric flow cytometry.

1996 • 5 citations

Ductal Carcinoma In-Situ Of The Breast: A new simplified histological classification. Association between cellular proliferation and c-erbB-2 protein expression

1992 • 4 citations